Clinical Trial

Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia

Study acronym: SONG
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth. In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital. Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route. Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-14.
Trial Details
NCT Number NCT05915663
Lead Sponsor Centre Hospitalier le Mans
Conditions Intubated Patient Requiring a Gastric Tube
Enrollment 2,400 participants
Start Date 2024-10-01
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-29